摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3,5-bis(methoxymethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | 1041434-12-1

中文名称
——
中文别名
——
英文名称
2-(3,5-bis(methoxymethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
英文别名
2-(3,5-Bis(methoxymethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[3,5-bis(methoxymethoxy)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
2-(3,5-bis(methoxymethoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane化学式
CAS
1041434-12-1
化学式
C16H25BO6
mdl
——
分子量
324.182
InChiKey
LFESADNDYAYOCR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    46 °C(Solv: ethyl ether (60-29-7))
  • 沸点:
    430.6±45.0 °C(Predicted)
  • 密度:
    1.10±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.95
  • 重原子数:
    23
  • 可旋转键数:
    7
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    55.4
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

点击查看最新优质反应信息

文献信息

  • Tailoring a Bacteriochlorin Building Block with Cationic, Amphipathic, or Lipophilic Substituents
    作者:Christian Ruzié、Michael Krayer、Thiagarajan Balasubramanian、Jonathan S. Lindsey
    DOI:10.1021/jo800736c
    日期:2008.8.1
    malleable molecules. To overcome these limitations, a synthetic free base 3,13-dibromobacteriochlorin (BC-Br3Br13) has been exploited as a building block in the synthesis of diverse bacteriochlorins via Pd-mediated coupling reactions (Sonogashira, Suzuki, and reductive carbonylation). Each bacteriochlorin is stable to adventitious dehydrogenation by virtue of the presence of a geminal dimethyl group in
    由于细菌氯在近红外(NIR)区域具有强吸收性,因此它们是多种医学适应症的光动力疗法(PDT)的有吸引力的候选者,但由于缺乏可稳定合成的可延展分子,因此其使用受到了阻碍。为了克服这些限制,合成了一种游离碱3,13-dibromobacteriochlorin(BC-Br 3 Br 13)已被用作通过Pd介导的偶联反应(Sonogashira,Suzuki和还原性羰基化)合成各种细菌绿素的基础。由于每个吡咯啉环中都存在双甲基二甲基基团,因此每种细菌二氯对意外脱氢均稳定。目标细菌绿素在3-和13-(β-吡咯基)位置带有阳离子,亲脂或两亲取代基。二羧基细菌二氯经由中间体二酰氯转化为酰胺衍生物。对二甲酰细菌二氯进行还原胺化,得到氨基甲基衍生物。通过Suzuki偶联引入一组带有亲脂性或两亲性基团的3,5-二取代的芳基。总共制备了22种游离碱细菌绿素。在每个分子的两个或四个胺位点上,将八个氨基烷基细菌二
  • [EN] THERAPEUTIC AGENTS TARGETING GPR35<br/>[FR] AGENTS THÉRAPEUTIQUES CIBLANT GPR35
    申请人:PROMETHEUS BIOSCIENCES INC
    公开号:WO2022020617A1
    公开(公告)日:2022-01-27
    Described herein are GPR35 modulators and methods of using these compounds in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
    本文描述了GPR35调节剂以及使用这些化合物治疗疾病、疾病或症状的方法。本文还描述了含有这些化合物的药物组合物。
  • Iridium-catalyzed C–H activation/borylation/oxidation for the preparation of bis-protected phloroglucinol derivatives
    作者:Laura J. Marshall、Karl M. Cable、Nigel P. Botting
    DOI:10.1016/j.tetlet.2010.03.049
    日期:2010.5
    The preparation of bis-protected phloroglucinol derivatives from a range of protected resorcinol substrates is presented. Functionalization was achieved via a two-step, one-pot iridium-catalyzed C-H activation/borylation/oxidation protocol. Our system gave high conversions to the arylboronic esters and good yields of the desired phenols following subsequent oxidation. A range of common protecting group categories was studied including alkyl, silyl, ether and ester. (C) 2010 Elsevier Ltd. All rights reserved.
  • 10th international symposium on the synthesis and applications of isotopes and isotopically labelled compounds-Wiley Young Scientist Awards Session 10, Tuesday, June 16, 2009
    作者:Larry Jones、Rhys Salter
    DOI:10.1002/jlcr.1767
    日期:——
    Addresses by the three of the four Wiley Young Scientist Award winners are highlighted. Copyright © 2010 John Wiley & Sons, Ltd.
    以下是四位威尔利青年科学家奖得主中的三位的发言亮点。版权所有© 2010年,约翰·威利父子出版公司。
查看更多